Epigenetic Profiling Tools, Technologies Primed for Clinic, Studies Suggest | GenomeWeb

NEW YORK (GenomeWeb) – Epigenetic profiling is poised for use in the clinic, including to help determine cancer subtypes and predict patient outcomes, according to a series of papers out today.

In four papers appearing in both Nature Biotechnology and Nature Communications, researchers from the European Blueprint project and the International Human Epigenome Consortium examined the accuracy of a number of epigenetic testing approaches as well as described their validation of genome­wide DNA methylation sequencing technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

Sponsored by
New England BioLabs

This webinar will provide an update on Phase 2 of the ongoing ABRF Next Generation Sequencing Study, an effort to evaluate the performance of NGS platforms and to identify optimal methods and best practices. Phase 1 of the study focused on RNA sequencing, while Phase 2 is focusing on genomic DNA samples.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.